Dünyadan Sağlık
|
FDA Patient Safety News FDA Press Releases and Talk Papers FDA Recalls, Withdrawals and Alerts CFSAN Food & Cosmetics Announcements |
Food and Drug Adminstration (FDA): Patient Safety News
FDA recently approved a new medical adhesive called Artiss to attach skin grafts onto burn patients. Artiss is made by Baxter Healthcare. Artiss has a lower thrombin concentration than other fibrin sealants, which gives surgeons more time to posi...
(Tue, 01 Jul 2008 04:00:00 GMT)New Medical Products: New Non-Refrigerated Coagulation Product
FDA has approved a new formulation of the genetically engineered version of Factor VIIa that does not need to be refrigerated. Factor VIIa is a plasma protein essential for blood clotting that can be used to treat and prevent bleeding in people with...
(Tue, 01 Jul 2008 04:00:00 GMT)Recalls and Safety Alerts: Update on Potentially Contaminated Heparin
Over the past several months, FDA has been alerting healthcare professionals and the public about medical products that may contain contaminated heparin, which has been associated with a number of serious adverse events. Here is an update and recomm...
(Tue, 01 Jul 2008 04:00:00 GMT)Recalls and Safety Alerts: FDA Takes Action on Injectable Colchicine
FDA is taking action against companies marketing injectable colchicine, which is an unapproved form of the drug. Colchicine is an anti-inflammatory used in the treatment of gout. Colchicine tablets, which are less hazardous, are not affected by FDA...
(Tue, 01 Jul 2008 04:00:00 GMT)Recalls and Safety Alerts: FDA Studying Heart Attack Risk with Ziagen, Videx
FDA has informed the health care community about ongoing safety reviews of several drugs. FDA is doing this as part of its commitment to inform health care professionals and the public about its ongoing drug safety reviews. Because the information ...
(Tue, 01 Jul 2008 04:00:00 GMT)Preventing Medical Errors: Preventing Fatal Overdoses with Cerebyx
The Institute for Safe Medication Practices (ISMP) and FDA are warning healthcare professionals that potentially fatal dosing errors continue to occur with the anti-epileptic drug Cerebyx (fosphenytoin), despite clarifications in the drug's labeling ...
(Tue, 01 Jul 2008 04:00:00 GMT)